A novel therapeutic, which is based on nanotechnology, turns off a critical gene and increases survival rates in mice with glioblastoma brain cancer, a new study reports.
A new study reports a novel combination of two targeted drugs dramatically slowed the growth of brain cancer tumors and significantly extended survival in mouse models.
Researchers delve deeply into the genomics of 599 GBM brain cancer cases to better target the disease.
Human glioma brain tumor cell growth was halted and erased in mice, according to new research.
The RIP1 protein can either protect or destroy brain tumors, a new study suggests.
Researchers suggest neural stem cells could be resistant to radiation. The stem cells could be roused from a hibernation-like state in order to reproduce and generate new cells which have the ability to migrate, replace injured cells and restore lost function.
Researchers discover a way to adjust the malignancy of glioma brain cancer cells in a newly developed 3D hydrogel. The new material mimics the conditions in the brain.
An experimental nanotechnology drug crosses the blood-brain barrier and targets brain tumor cells, a new study suggests. The drug also blocks the growth of tumor blood vessels.
Researchers have developed a new approach for treating glioblastoma brain cancer. The findings are shown to extend the life of animals treated for the cancer.
Researchers discover an enzyme, IDH, which facilitates the breakdown of specific amino acids makes glioblastoma brain cancer particularly aggressive.